THE WASHINGTON TAX & PUBLIC POLICY GROUP for ALLIANCE FOR BIOPHARMACEUTICAL COMPETITIVENESS AND INNOVATION
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues related to corporate and international taxation. Issues related to OECD Pillar 1 and Pillar 2 negotiations, agreements, implementation, and reporting related to the taxation of global income. Issues related to the taxation of intellectual property income. Issues related to foreign country tax administration and extraterritorial taxes. Issues related to IRC sections 11, 41 and 174, 45C, 55, 56A, and 59, 59A, 163(j), 250, 951A, 954(d) and 954(e), and 960(d)(2). (H.R. 10431)
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY NICKERSON | Tax Counsel, Ways and Means Committee; Staff Director, Ways and Means Select Revenue Measures Subcommittee |
| JAMES MAX PEDROTTI New | Legislative Correspondent, Legislative Assistant, Senior Legislative Assistant, Legislative Director, Deputy Chief of Staff to Rep. Carol Miller |
| ZACHARY AUSTIN PRICE | Staff Assistant to Sen. Coats |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.